Europe Guillain-Barre Syndrome Market Size, Share & Trends Analysis Report By Therapeutics (Intravenous Immunoglobulin, Plasma Exchange, and Others), By Route Of Administration, By Distribution Channel, By Country and Growth Forecast, 2023

List of Tables

The Europe Guillain-Barre Syndrome Market would witness market growth of 4.4% CAGR during the forecast period (2023-2030).

The Germany market dominated the Europe Guillain-Barre Syndrome Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $57,999.6 Thousands by 2030. The UK market is exhibiting a CAGR of 3.5% during (2023 - 2030). Additionally, The France market would experience a CAGR of 5.2% during (2023 - 2030).

The applications of the Guillain-Barre syndrome market encompass various aspects of diagnosis, treatment, supportive care, and rehabilitation, all aimed at improving patient outcomes and quality of life. Accurate and timely diagnosis of GBS is essential for initiating appropriate treatment and managing the condition effectively.

Moreover, nerve conduction studies (NCS) measure the electrical signal intensity and speed as they travel along peripheral nerves to assess nerve function. Abnormalities in nerve conduction velocities and amplitudes indicate nerve damage characteristic of GBS.

Likewise, specialized neurology clinics in Spain, such as Hospital Clinic de Barcelona or Hospital Universitario La Paz in Madrid, are dedicated to diagnosing and managing neurological disorders, including GBS. Therefore, the market is growing due to the expansion of the healthcare industry and the development of rehabilitation facilities in the region.

Based on Therapeutics, the market is segmented into Intravenous Immunoglobulin, Plasma Exchange, and Others. Based on Route of Administration, the market is segmented into Parenteral, and Oral. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

F. Hoffmann-La Roche Ltd.
Pfizer, Inc.
PTC, Inc.
AstraZeneca PLC
Novartis AG
Novo Nordisk A/S
Takeda Pharmaceutical Company Limited
Bayer AG
Merck & Co., Inc.
Bristol Myers Squibb Company

Europe Guillain-Barre Syndrome Market Report Segmentation

By Therapeutics

Intravenous Immunoglobulin
Plasma Exchange
Others

By Route Of Administration

Parenteral
Oral

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Others

By Country

Germany
UK
France
Russia
Spain
Italy
Rest of Europe

Chapter 1.Market Scope & Methodology

1.1Market Definition
1.2Objectives
1.3Market Scope
1.4Segmentation
- 1.4.1Europe Guillain-Barre Syndrome Market, by Therapeutics
- 1.4.2Europe Guillain-Barre Syndrome Market, by Route Of Administration
- 1.4.3Europe Guillain-Barre Syndrome Market, by Distribution Channel
- 1.4.4Europe Guillain-Barre Syndrome Market, by Country
1.5Methodology for the research

Chapter 2.Market at a Glance

2.1Key Highlights

Chapter 3.Market Overview

3.1Introduction
- 3.1.1Overview
  - 3.1.1.1Market Composition and Scenario
3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
3.3Porter Five Forces Analysis

Chapter 4.Europe Guillain-Barre Syndrome Market by Therapeutics

4.1Europe Intravenous Immunoglobulin Market by Country
4.2Europe Plasma Exchange Market by Country
4.3Europe Others Market by Country

Chapter 5.Europe Guillain-Barre Syndrome Market by Route Of Administration

5.1Europe Parenteral Market by Country
5.2Europe Oral Market by Country

Chapter 6.Europe Guillain-Barre Syndrome Market by Distribution Channel

6.1Europe Hospital Pharmacies Market by Country
6.2Europe Retail Pharmacies Market by Country
6.3Europe Others Market by Country

Chapter 7.Europe Guillain-Barre Syndrome Market by Country

7.1Germany Guillain-Barre Syndrome Market
- 7.1.1Germany Guillain-Barre Syndrome Market by Therapeutics
- 7.1.2Germany Guillain-Barre Syndrome Market by Route Of Administration
- 7.1.3Germany Guillain-Barre Syndrome Market by Distribution Channel
7.2UK Guillain-Barre Syndrome Market
- 7.2.1UK Guillain-Barre Syndrome Market by Therapeutics
- 7.2.2UK Guillain-Barre Syndrome Market by Route Of Administration
- 7.2.3UK Guillain-Barre Syndrome Market by Distribution Channel
7.3France Guillain-Barre Syndrome Market
- 7.3.1France Guillain-Barre Syndrome Market by Therapeutics
- 7.3.2France Guillain-Barre Syndrome Market by Route Of Administration
- 7.3.3France Guillain-Barre Syndrome Market by Distribution Channel
7.4Russia Guillain-Barre Syndrome Market
- 7.4.1Russia Guillain-Barre Syndrome Market by Therapeutics
- 7.4.2Russia Guillain-Barre Syndrome Market by Route Of Administration
- 7.4.3Russia Guillain-Barre Syndrome Market by Distribution Channel
7.5Spain Guillain-Barre Syndrome Market
- 7.5.1Spain Guillain-Barre Syndrome Market by Therapeutics
- 7.5.2Spain Guillain-Barre Syndrome Market by Route Of Administration
- 7.5.3Spain Guillain-Barre Syndrome Market by Distribution Channel
7.6Italy Guillain-Barre Syndrome Market
- 7.6.1Italy Guillain-Barre Syndrome Market by Therapeutics
- 7.6.2Italy Guillain-Barre Syndrome Market by Route Of Administration
- 7.6.3Italy Guillain-Barre Syndrome Market by Distribution Channel
7.7Rest of Europe Guillain-Barre Syndrome Market
- 7.7.1Rest of Europe Guillain-Barre Syndrome Market by Therapeutics
- 7.7.2Rest of Europe Guillain-Barre Syndrome Market by Route Of Administration
- 7.7.3Rest of Europe Guillain-Barre Syndrome Market by Distribution Channel

Chapter 8.Company Profiles

8.1F. Hoffmann-La Roche Ltd.
- 8.1.1Company Overview
- 8.1.2Financial Analysis
- 8.1.3Segmental and Regional Analysis
- 8.1.4Research & Development Expense
- 8.1.5SWOT Analysis
8.2Pfizer, Inc.
- 8.2.1Company Overview
- 8.2.2Financial Analysis
- 8.2.3Regional & Segmental Analysis
- 8.2.4Research & Development Expense
- 8.2.5SWOT Analysis
8.3PTC, Inc.
- 8.3.1Company Overview
- 8.3.2Financial Analysis
- 8.3.3Segmental and Regional Analysis
- 8.3.4Research & Development Expenses
- 8.3.5SWOT Analysis
8.4AstraZeneca PLC
- 8.4.1Company Overview
- 8.4.2Financial Analysis
- 8.4.3Regional Analysis
- 8.4.4Research & Development Expenses
- 8.4.5SWOT Analysis
8.5Novartis AG
- 8.5.1Company Overview
- 8.5.2Financial Analysis
- 8.5.3Segmental and Regional Analysis
- 8.5.4Research & Development Expense
- 8.5.5Recent strategies and developments:
  - 8.5.5.1Partnerships, Collaborations, and Agreements:
- 8.5.6SWOT Analysis
8.6Novo Nordisk A/S
- 8.6.1Company Overview
- 8.6.2Financial Analysis
- 8.6.3Segmental and Regional Analysis
- 8.6.4Research & Development Expenses
- 8.6.5SWOT Analysis
8.7Takeda Pharmaceutical Company Limited
- 8.7.1Company Overview
- 8.7.2Financial Analysis
- 8.7.3Regional Analysis
- 8.7.4Research & Development Expense
- 8.7.5SWOT Analysis
8.8Bayer AG
- 8.8.1Company Overview
- 8.8.2Financial Analysis
- 8.8.3Segmental and Regional Analysis
- 8.8.4Research & Development Expense
- 8.8.5SWOT Analysis
8.9Merck & Co., Inc.
- 8.9.1Company Overview
- 8.9.2Financial Analysis
- 8.9.3Segmental and Regional Analysis
- 8.9.4Research & Development Expenses
- 8.9.5Recent strategies and developments:
  - 8.9.5.1Partnerships, Collaborations, and Agreements:
- 8.9.6SWOT Analysis
8.10.Bristol Myers Squibb Company
- 8.10.1Company Overview
- 8.10.2Financial Analysis
- 8.10.3Regional Analysis
- 8.10.4Research & Development Expenses
- 8.10.5SWOT Analysis

LIST OF TABLES

TABLE 1Europe Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 2Europe Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 3Europe Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 4Europe Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 5Europe Intravenous Immunoglobulin Market by Country, 2019 - 2022, USD Thousands
TABLE 6Europe Intravenous Immunoglobulin Market by Country, 2023 - 2030, USD Thousands
TABLE 7Europe Plasma Exchange Market by Country, 2019 - 2022, USD Thousands
TABLE 8Europe Plasma Exchange Market by Country, 2023 - 2030, USD Thousands
TABLE 9Europe Others Market by Country, 2019 - 2022, USD Thousands
TABLE 10Europe Others Market by Country, 2023 - 2030, USD Thousands
TABLE 11Europe Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 12Europe Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 13Europe Parenteral Market by Country, 2019 - 2022, USD Thousands
TABLE 14Europe Parenteral Market by Country, 2023 - 2030, USD Thousands
TABLE 15Europe Oral Market by Country, 2019 - 2022, USD Thousands
TABLE 16Europe Oral Market by Country, 2023 - 2030, USD Thousands
TABLE 17Europe Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 18Europe Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 19Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 20Europe Hospital Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 21Europe Retail Pharmacies Market by Country, 2019 - 2022, USD Thousands
TABLE 22Europe Retail Pharmacies Market by Country, 2023 - 2030, USD Thousands
TABLE 23Europe Others Market by Country, 2019 - 2022, USD Thousands
TABLE 24Europe Others Market by Country, 2023 - 2030, USD Thousands
TABLE 25Europe Guillain-Barre Syndrome Market by Country, 2019 - 2022, USD Thousands
TABLE 26Europe Guillain-Barre Syndrome Market by Country, 2023 - 2030, USD Thousands
TABLE 27Germany Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 28Germany Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 29Germany Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 30Germany Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 31Germany Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 32Germany Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 33Germany Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 34Germany Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 35UK Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 36UK Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 37UK Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 38UK Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 39UK Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 40UK Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 41UK Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 42UK Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 43France Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 44France Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 45France Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 46France Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 47France Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 48France Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 49France Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 50France Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 51Russia Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 52Russia Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 53Russia Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 54Russia Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 55Russia Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 56Russia Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 57Russia Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 58Russia Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 59Spain Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 60Spain Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 61Spain Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 62Spain Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 63Spain Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 64Spain Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 65Spain Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 66Spain Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 67Italy Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 68Italy Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 69Italy Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 70Italy Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 71Italy Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 72Italy Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 73Italy Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 74Italy Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 75Rest of Europe Guillain-Barre Syndrome Market, 2019 - 2022, USD Thousands
TABLE 76Rest of Europe Guillain-Barre Syndrome Market, 2023 - 2030, USD Thousands
TABLE 77Rest of Europe Guillain-Barre Syndrome Market by Therapeutics, 2019 - 2022, USD Thousands
TABLE 78Rest of Europe Guillain-Barre Syndrome Market by Therapeutics, 2023 - 2030, USD Thousands
TABLE 79Rest of Europe Guillain-Barre Syndrome Market by Route Of Administration, 2019 - 2022, USD Thousands
TABLE 80Rest of Europe Guillain-Barre Syndrome Market by Route Of Administration, 2023 - 2030, USD Thousands
TABLE 81Rest of Europe Guillain-Barre Syndrome Market by Distribution Channel, 2019 - 2022, USD Thousands
TABLE 82Rest of Europe Guillain-Barre Syndrome Market by Distribution Channel, 2023 - 2030, USD Thousands
TABLE 83Key Information - F. Hoffmann-La Roche Ltd.
TABLE 84Key Information - Pfizer, Inc.
TABLE 85key Information - PTC, Inc.
TABLE 86KEY INFORMATION - AstraZeneca PLC
TABLE 87Key Information - Novartis AG
TABLE 88Key Information - Novo Nordisk A/S
TABLE 89Key Information - Takeda Pharmaceutical Company Limited
TABLE 90Key Information - Bayer AG
TABLE 91Key Information - Merck & Co., Inc.
TABLE 92Key Information - Bristol Myers Squibb Company

Europe Guillain-Barre Syndrome Market Size, Share & Trends Analysis Report By Therapeutics (Intravenous Immunoglobulin, Plasma Exchange, and Others), By Route Of Administration, By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents